- Preamble [SYSTEM]
- Fund & Investor Interest
- Street Moves
- Solebury Trout Updates
- Market Commentary
- IPO News
- Expert Interactions
- Banker Comments & Notes
- Conference Snippet
- Industry Snippets
- Solebury Trout Talks
Solebury Trout Talks: Interview with Alex Zapesochny, Clerio Vision - Part of the NameTag Series
Alex is an experienced technology executive and attorney who previously served as Executive Vice President of Cardiac Safety at ERT.
A co-founder of iCardiac Technologies, Alex served as its President and CEO until ERT acquired the company in late 2017. He founded iCardiac with Mike Totterman and Sasha Latypova.
Prior to joining iCardiac, Alex was General Counsel and Director of Business Development for Lenel Systems International, a developer and global supplier of high-end software, products and services for the security industry.
Alex was part of a small executive management team that guided the company to extraordinary growth. The company expanded to serving over 10,000 organizations throughout 75 countries, including security-conscious entities such as Microsoft, Cisco, all three New York City-area airports, the Department of Homeland Security and over 60 percent of all Fortune 100 companies. The company’s financial growth earned it 39th place on Inc. magazine’s ranking of the nation’s fastest-growing privately-held companies, and Lenel was acquired for $440 million by United Technologies Corporation (NYSE: UTX) in March 2005.Alex remained with UTC after the acquisition and continued in his legal and business development roles within the Lenel Systems subsidiary.
Alex, who is known for interest in entrepreneurial activity, provides legal and business counsel to early-stage companies. He has been a trial attorney during his tenure as a New York City prosecutor, a policy division staff member in the Washington headquarters of a presidential campaign, and Co-Founder and Executive Director of an award-winning non-profit that expands the national registry of potential bone marrow and blood stem cell donors.
Alex received his undergraduate degree from Cornell University and graduate degrees from American University, University of Oxford and the University of Cambridge.